Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17231916 | 1.00 | CHRM1 (0.50) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL2230112 | 0.86 | CA2 (0.56) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL8072808 | 0.84 | HSPD1 (0.56) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL29221539 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL29106827 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL29118074 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL14119619 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL9293381 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL21247622 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 | |
| SCHEMBL4864116 | 0.82 | HSPD1 (0.59) | CA2MAPK1HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295693-A | Spin-on metal-organic formulations | 默克专利股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116535997-A | POE adhesive film for improving binding force of heterojunction battery and preparation method thereof | 苏州明冠新材料科技有限公司 | 2023-08-04 | — | — | CN | claimed |
| CN-118165664-A | High-weather-resistance solar cell power-lifting packaging adhesive film, preparation method thereof and solar cell | 明冠新材料股份有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-117295693-A | Spin-on metal-organic formulations | 默克专利股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116535997-A | POE adhesive film for improving binding force of heterojunction battery and preparation method thereof | 苏州明冠新材料科技有限公司 | 2023-08-04 | — | — | CN | disclosed |
| US-9206206-B2 | Oxidized lipid compounds and uses thereof | VASCULAR BIOGENICS LTD. (IL) | 2015-12-08 | — | — | US | disclosed |
| US-8969348-B2 | Chymase inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2015-03-03 | — | — | US | disclosed |
| EP-2826369-A2 | Oxidized lipid compounds and uses thereof | Vascular Biogenics Ltd. (IL) | 2015-01-21 | — | — | EP | disclosed |
| EP-2826370-A2 | Oxidized lipid compounds and uses thereof | Vascular Biogenics Ltd. (IL) | 2015-01-21 | — | — | EP | disclosed |
| EP-2348866-B1 | OXIDIZED LIPID COMPOUNDS AND USES THEREOF | VASCULAR BIOGENICS LTD (IL) | 2015-01-07 | — | — | EP | disclosed |
| CN-103221376-A | Glycidyl esters of alpha, alpha-branched neononanoic acids, their synthesis and use | MOMENTIVE SPECIALTY CHEM INC | 2013-07-24 | — | — | CN | disclosed |
| WO-2001013958-A2 | DRUG CONJUGATES AND METHODS OF DESIGNING THE SAME | BRENNER SYDNEY (US) | 2001-03-01 | — | — | WO | disclosed |
| WO-2001000675-A1 | PROTAMINE-FREE INSOLUBLE ACYLATED INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 2001-01-04 | — | — | WO | disclosed |
| WO-2001000674-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2001-01-04 | — | — | WO | disclosed |
| WO-2000064940-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2000-11-02 | — | — | WO | disclosed |
| WO-1999032116-A1 | INSOLUBLE COMPOSITIONS FOR CONTROLLING BLOOD GLUCOSE | ELI LILLY AND COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |
| EP-0925792-A2 | Insoluble compositions for controlling blood glucose | ELI LILLY AND COMPANY (US) | 1999-06-30 | — | — | EP | disclosed |
| WO-1999021578-A1 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0000161-B1 | PROCESS FOR REDUCING THE AMOUNT OF RESIDUAL MONOMERS DURING THE POLYMERISATION OF VINYL LACTAMS AND VINYL ESTERS | BASF Aktiengesellschaft (DE) | 1981-05-20 | — | — | EP | disclosed |
| EP-0000161-A1 | Process for reducing the amount of residual monomers during the polymerisation of vinyl lactams and vinyl esters | BASF Aktiengesellschaft (DE) | 1979-01-10 | — | — | EP | disclosed |